TCL Archive ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb By Cancer History Project January 30, 2009
TCL Archive ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent. By Cancer History Project March 21, 2008
TCL Archive ODAC Member Critical Of Amgen For Price Incentives. By Cancer History Project March 21, 2008
TCL Archive ODAC Recommends Approval Of Nplate For Thrombocytopenia. By Cancer History Project March 21, 2008
TCL Archive ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent. By Cancer History Project March 14, 2008
TCL Archive New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again. By Cancer History Project January 11, 2008
TCL Archive ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction. By Cancer History Project July 27, 2007
TCL Archive After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency. By Cancer History Project May 18, 2007
ArticleSpotlight Article A Vote for Cancer: Tobacco Advertising and Presidential Elections By The Center for the Study of Tobacco and Society